Mycio Wealth Partners, LLC Gilead Sciences, Inc. Transaction History

Mycio Wealth Partners, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $230,854 - $295,690	-3,686 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $1,663 - $1,830	27 Added 0.74%	3,686 $240,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $12,814 - $14,145	205 Added 5.94%	3,659 $232,000
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $2,969 - $3,330	48 Added 1.41%	3,454 $233,000
Q1 2019 Apr 18, 2019	BUY	$62.53 - $70.05 $1,750 - $1,961	28 Added 0.83%	3,406 $221,000

Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $78,580 - $102,542	-1,298 Reduced 27.76%	3,378 $211,000
Q3 2018 Oct 25, 2018	SELL	$71.28 - $78.92 $213,697 - $236,602	-2,998 Reduced 39.07%	4,676 $361,000
Q2 2018 Jul 19, 2018	BUY	$64.88 - $75.68 $324 - $378	5 Added 0.07%	7,674 $544,000
Q1 2018 Apr 27, 2018	SELL	$72.84 - $88.8 $214,368 - $261,338	-2,943 Reduced 27.73%	7,669 $578,000
Q4 2017 Jan 31, 2018	BUY	$71.15 - $83.52 $13,233 - $15,534	186 Added 1.78%	10,612 $766,000
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $24,373 - $28,888	338 Added 3.35%	10,426 $844,000
Q2 2017 Aug 10, 2017	SELL	N/A	-58 Reduced 0.57%	10,088 $714,000
Q2 2017 Aug 08, 2017	BUY	N/A	10,146	10,146 $689,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $84.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Mycio Wealth Partners, LLC with notifications on news.